Product Information
MECLIZINE 12.5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0464 per EA under NDC 00904737561. Its NADAC has been published 132 times since Dec 20, 2023.
Strength
12.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904737561
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201451On Market Since
4/22/2022
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG TABLET has been published 132 times since Dec 20, 2023, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0464 per EA |
|---|---|
| All-time high | $0.0893 (Feb 14, 2024) |
| All-time low | $0.0418 (Nov 20, 2024) |
| 52-week high | $0.0535 |
| 52-week low | $0.0461 |
| Median price | $0.0516 |
| Average price | $0.0545 |
| Largest weekly change | -29.2% (Nov 20, 2024) |
| Weeks tracked | 132 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0464 per EA (NDC 00904737561), effective Jun 24, 2026.
How has the price of MECLIZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has declined 33.8%. It has been tracked across 132 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?
Since Dec 20, 2023, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0418 (Nov 20, 2024) to a high of $0.0893 (Feb 14, 2024), with a median of $0.0516 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MECLIZINE 12.5 MG TABLET, is $0.0309 per EA — about 33% below MECLIZINE 12.5 MG TABLET.
Who manufactures MECLIZINE 12.5 MG TABLET?
MECLIZINE 12.5 MG TABLET (NDC 00904737561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification